TRIM29 (tripartite motif containing 29)

2003-06-01  

Identity

HGNC
LOCATION
11q23.3
LOCUSID
ALIAS
ATDC
FUSION GENES

Other Information

Locus ID:

NCBI: 23650
MIM: 610658
HGNC: 17274
Ensembl: ENSG00000137699

Variants:

dbSNP: 23650
ClinVar: 23650
TCGA: ENSG00000137699
COSMIC: TRIM29

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000137699ENST00000341846Q14134
ENSG00000137699ENST00000341846A0A024R3J1
ENSG00000137699ENST00000475051E9PJD4
ENSG00000137699ENST00000526881E9PPX1
ENSG00000137699ENST00000528870E9PIQ2
ENSG00000137699ENST00000529011E9PJ94
ENSG00000137699ENST00000529040E9PM74
ENSG00000137699ENST00000529044E9PRL4
ENSG00000137699ENST00000529495E9PLI4
ENSG00000137699ENST00000531555H0YD78
ENSG00000137699ENST00000532833E9PI31
ENSG00000137699ENST00000533302H0YF27
ENSG00000137699ENST00000627238E9PJD4

Expression (GTEx)

0
100
200
300
400
500
600
700
800

Pathways

PathwaySourceExternal ID
Immune SystemREACTOMER-HSA-168256
Cytokine Signaling in Immune systemREACTOMER-HSA-1280215
Interferon SignalingREACTOMER-HSA-913531
Interferon gamma signalingREACTOMER-HSA-877300

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
376447522024Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis via Binding RAD50.0
380298302024TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer.2
383457492024O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to glucose deficiency.0
383934402024TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma.0
385187272024TRIM29 facilitates gemcitabine resistance via MEK/ERK pathway and is modulated by circRPS29/miR-770-5p axis in PDAC.0
376447522024Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis via Binding RAD50.0
380298302024TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer.2
383457492024O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to glucose deficiency.0
383934402024TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma.0
385187272024TRIM29 facilitates gemcitabine resistance via MEK/ERK pathway and is modulated by circRPS29/miR-770-5p axis in PDAC.0
368764222023lncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression.2
377176922023NAP1L5 facilitates pancreatic ductal adenocarcinoma progression via TRIM29-mediated ubiquitination of PHLPP1.0
368764222023lncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression.2
377176922023NAP1L5 facilitates pancreatic ductal adenocarcinoma progression via TRIM29-mediated ubiquitination of PHLPP1.0
349733912022TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer.8

Citation

Dessen P

TRIM29 (tripartite motif containing 29)

Atlas Genet Cytogenet Oncol Haematol. 2003-06-01

Online version: http://atlasgeneticsoncology.org/gene/42701/trim29